Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen's Shares Transferred to Pink Sheets

NEW YORK (GenomeWeb News) – Nanogen's shares began trading on the OTC Pink Sheets this morning after being removed from the Nasdaq market.

The transfer of the firm's common stock was expected after it announced a week and a half ago that it had received a delisting notice, which it did not intend to appeal.

As reported a week ago by GenomeWeb Daily News, Nanogen was subject to delisting because it has not paid certain outstanding fees as required for continued listing on the exchange. The firm also mentioned at the time that it had received a notice of default from General Electric related to the financing of certain equipment operated by Nanogen. The firm had failed to make certain scheduled principal and interest payments to GE under an agreement signed in June 2001.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.